The repository administrator has not yet configured an RDF license.
SAFETY AND EFFICACY OF LONG-TERM TREATMENT WITH NUCLEOS(T)IDE ANALOGUES IN CHRONIC HEPATITIS B
Chronic hepatitis B (CHB) remains a major global public health problem, leading to progressive liver disease, cirrhosis, and hepatocellular carcinoma. Long-term antiviral therapy with nucleos(t)ide analogues (NAs) is the cornerstone of CHB management, aiming to suppress hepatitis B virus (HBV) replication, prevent disease progression, and reduce liver-related complications. Despite proven antiviral efficacy, prolonged NA therapy raises concerns regarding drug resistance, safety, renal and bone toxicity, and long-term patient adherence. This study was conducted at the Khorezm Regional Multidisciplinary Medical Center and aimed to evaluate the safety and efficacy of long-term treatment with nucleos(t)ide analogues in patients with chronic hepatitis B. Patients were assessed based on virological, biochemical, and clinical parameters during extended antiviral therapy. The results demonstrate that long-term NA treatment effectively suppresses HBV replication, improves liver function, and is generally well tolerated, confirming the importance of continuous antiviral therapy in the management of chronic hepatitis B.
Multidisciplinary Journal of Science and Technology
HTML Summary of #65418 SAFETY AND EFFICACY OF LONG-TERM TREATMENT WITH NUCLEOS(T)IDE ANALOGUES IN CHRONIC HEPATITIS B